A Look At Merck's Late-Stage Pharmaceuticals Pipeline [Forbes]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Forbes
This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. (AP Photo/Seth Wenig, File) photocredit: ASSOCIATED PRESS Merck (NYSE:MRK) has a strong late stage pharmaceuticals pipeline, and it could be worth as much as $13 billion, or over 6% of its current market value, according to our estimates. Several drugs in the pipeline are capable of generating more than $1 billion in peak sales. Merck’s drug pipeline value can primarily be attributed to its vaccines, and anti-infectious drugs. We have created an interactive dashboard ~ How Large Is Merck’s Late Stage Pharmaceuticals Pipeline ~ which shows key factors determining the late stage pharmaceuticals pipeline’s value such as expected peak sales, expected growth trajectory, and probability of market approval. You can modify these assumptions to see how it impacts Merck’s pipeline revenue forecast and valuation. Vaccines Probability-Adjusted Revenue Could Be North of $2 Billion
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck Lifts Full-Year 2024 Outlook Following First-Quarter Beat [Yahoo! Finance]Yahoo! Finance
- Scholz Gets Another Pharma Boost With New Merck KGaA Site [BNN Bloomberg (Canada)]BNN Bloomberg
- WebMD Ignite Unveils HealthHub Interactive to Support Health Plans' Clinical Programs [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers posts Q1 beat despite growth headwinds [Seeking Alpha]Seeking Alpha
- Merck raises guidance as Keytruda sales jump 20% in Q1 [Seeking Alpha]Seeking Alpha
MRK
Earnings
- 4/25/24 - Beat
MRK
Sec Filings
- 4/25/24 - Form 8-K
- 4/11/24 - Form ARS
- 4/11/24 - Form DEFA14A
- MRK's page on the SEC website